摘要
背景:白质疏松症(Leukoaraisis,LA)是老年人常见的影像学表现,常伴有多种临床疾患,包括不明原因的头晕。LA的发病机制是多因素的,脑微循环功能障碍导致慢性低灌注和组织丢失,并伴有氧化应激。目的:分析LA患者的氧化应激标志物。方法:连续55例LA患者,男33例,中位年龄75岁.在33名患有LA和不明原因头晕的患者中,我们进行了一项开放式研究,以评估60天补充多酚化合物是否可以改变这些生物标志物并影响生活质量,用眩晕障碍量表(DHI)进行分析。结果:在基线状态下,血氧化应激参数值超出正常范围,与正常对照组比较,差异有显着性(P<0.05)。经过两个月的补充,我们观察到高级氧化蛋白产物值显著下降,DHI值显著改善。结论:氧化应激生物标志物可用于检测LA氧化还原失衡,为监测病情及治疗反应提供无创工具。
关键词: 白质疏松症,脑小血管疾病,头晕,氧化应激,多酚,DHI。
Current Molecular Medicine
Title:Oxidative Stress in Cerebral Small Vessel Disease Dizziness Patients, Basally and After Polyphenol Compound Supplementation
Volume: 18 Issue: 3
关键词: 白质疏松症,脑小血管疾病,头晕,氧化应激,多酚,DHI。
摘要: Background: Leukoaraiosis (LA) is a common radiological finding in elderly, frequently associated with several clinical disorders, including unexplained dizziness. The pathogenesis of LA is multifactorial, with a dysfunction of cerebral microcirculation resulting in chronic hypoperfusion and tissue loss, with oxidative stress involved in this cascade.
Objective: The aim of this study was to analyse some oxidative stress biomarkers in a cohort of LA patients.
Method: Fifty-five consecutive patients (33 males, median age 75 years) with LA were recruited. In a subgroup of 33 patients with LA and unexplained dizziness, we have then performed an open study to evaluate if 60-day supplementation with a polyphenol compound may modify these biomarkers and influence quality of life, analysed with the Dizziness Handicap Inventory (DHI) scale.
Results: At baseline, blood oxidative stress parameters values were outside normal ranges and compared to matched healthy controls. After the two months supplementation, we observed a significant decrement of advanced oxidation protein products values and a significant improvement of DHI.
Conclusion: Oxidative stress biomarkers may be useful to detect redox imbalance in LA and to provide non-invasive tools to monitor disease status and response to therapy.
Export Options
About this article
Cite this article as:
Oxidative Stress in Cerebral Small Vessel Disease Dizziness Patients, Basally and After Polyphenol Compound Supplementation, Current Molecular Medicine 2018; 18 (3) . https://dx.doi.org/10.2174/1566524018666180720165055
DOI https://dx.doi.org/10.2174/1566524018666180720165055 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hydrochlorothiazide vs. Chlorthalidone as the Optimal Diuretic for the Management of Hypertension
Current Pharmaceutical Design In-hospital Falls in Older Patients: The Risk Factors and The Role of Hyponatraemia
Current Aging Science In Utero Gene Therapy: Prospect and Future
Current Pharmaceutical Design Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Current Drug Targets Subject Index to Volume 5
Current Drug Targets Diabetes and the Chronic Care Model: A Review
Current Diabetes Reviews Fenofibrate and Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease
Current Drug Targets Associating Paracrine Communication to Regenerative Medicine: Search Strategies & Major Trends in Scientific and Patent Production
Recent Patents on Regenerative Medicine Systemic Administration of Fluoro-Gold for the Histological Assessment of Vascular Structure, Integrity and Damage
Current Neurovascular Research Leptin as Clinical Target
Recent Patents on Inflammation & Allergy Drug Discovery Soy Isoflavones and Cardiovascular Health: An Update
Current Nutrition & Food Science Male Urogenital Disorders and Metabolic Syndrome: Possible Links, Characteristics and Potential Treatment Strategies
Current Pharmaceutical Design Post-Stroke Immunodepression and Infection: An Emerging Concept
Infectious Disorders - Drug Targets Diabetic Medications in Pregnancy
Current Diabetes Reviews Choice of Treatment with Antidepressants: Influencing Factors
Current Pharmaceutical Design Lysophospholipids: Synthesis and Biological Aspects
Current Organic Chemistry Repeated Restraint and Nerve Growth Factor Administration in Male and Female Mice: Effect on Sympathetic and Cardiovascular Mediators of the Stress Response
Current Neurovascular Research Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Systemic Sclerosis-Related Interstitial Lung Disease
Current Respiratory Medicine Reviews